findmyKOL

Lowell Lo, MD

Basic profile

Nephrology

ORCID↗NPI↗
RegionDallas, TX · South CentralSpecialtyNephrologyFocusNephrology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Lowell Lo is a Nephrology physician. OpenAlex indexes 29 publications with 1,459 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
29publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,459citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5201 Harry Hines Blvd
House Staff & Gme
Dallas, TX 752357708

Telephone

214-590-8058

Registry record last updated 15 Nov 2017.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    61.5%
    Beta blocker15.5%
    Carvedilol65%Metoprolol Succinate35%
    Part D≥27 patients
    Angiotensin receptor blocker (ARB)12.2%
    Losartan Potassium75%Olmesartan Medoxomil25%
    Part D<11 patients

    + 9 more classes in this area

  • Metabolism & gastrointestinal

    14.3%
    H2 blocker6.6%
    Famotidine100%
    Part D<11 patients
    Vitamin D3 Analog4.3%
    Calcitriol100%
    Part D≥12 patients

    + 2 more classes in this area

  • Other

    10.9%
    Phosphate Binder6.6%
    Sevelamer Carbonate100%
    Part D≥25 patients
    Drugs for treatment of hyperkalemia and hyperphosphatemia4.3%
    Lokelma69%Lanthanum Carbonate31%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”